Table 1 |
|||||||
|
Overview of the standardized content of a CRF used for pharmacological studies according to the consensus. Measurements at each visit are graded according to essential to collect (A) or highly recommended (B). |
|||||||
|
Screening |
Baseline |
Week 2 |
Week 4 |
Week 8 |
Week 12 = End |
Week 16 Follow up |
|
|
|
|||||||
|
TSCHQ |
A |
||||||
|
|
|||||||
|
Otological Examination |
A |
||||||
|
|
|||||||
|
Medical history |
A |
||||||
|
|
|||||||
|
Audiometry |
A |
A |
B |
||||
|
|
|||||||
|
Loudness match |
B |
B |
|||||
|
|
|||||||
|
Pitch match |
B |
B |
|||||
|
|
|||||||
|
Maskability |
B |
B |
|||||
|
|
|||||||
|
Residual Inhibition |
B |
B |
|||||
|
|
|||||||
|
THI |
A |
A |
A |
A |
A |
A |
A |
|
|
|||||||
|
TBF 12 |
B |
B |
B |
B |
B |
B |
B |
|
|
|||||||
|
Tinnitus Numeric Rating Scales |
A |
A |
A |
A |
A |
A |
A |
|
|
|||||||
|
BDI |
B |
B |
B |
B |
B |
B |
B |
|
|
|||||||
|
WHOQOL |
B |
B |
B |
B |
B |
B |
B |
|
|
|||||||
|
CGI (change) |
A |
A |
A |
A |
A |
||
|
|
|||||||
|
Concomittant medication |
A |
A |
A |
A |
A |
A |
A |
|
|
|||||||
|
Adverse Events |
A |
A |
A |
A |
A |
||
|
|
|||||||
|
Comorbidity |
A |
A |
A |
A |
A |
A |
A |
|
|
|||||||
|
Landgrebe et al. BMC Medical Informatics and Decision Making 2010 10:42 doi:10.1186/1472-6947-10-42 |
|||||||